Here are five highlights:
1. The VRS system is intended to help patients suffering from glenoid vault/socket extreme bone loss.
2. The technology represents the first patient-matched glenoid implant commercially available.
3. Drs. Mallo and Schrank serve as co-chiefs of the shoulder service at St. Charles Orthopedics in East Setauket, N.Y.
4. Dr. Mallo completed a shoulder reconstruction and arthroscopy fellowship at Harvard University/The Boston Shoulder Institute.
5. Dr. Schrank completed a sports medicine fellowship at Kerlan-Jobe Orthopaedic Clinic in Los Angeles.
More articles on devices:
Stryker, Zimmer Biomet, SeaSpine & more: 24 device company key notes
North America dominates pedicle screw systems market: 3 observations
SeaSpine ranks 3rd among top NASDAQ medical device stocks for first half of 2017 — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
